death-ligand相关论文
Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1
In recent years,immune checkpoint inhibitors(ICIs)have made breakthroughs in the field of lung cancer and have become a ......
Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor:A c
BACKGROUND Thymic epithelial carcinomas are rare and have a poor prognosis.Treatment of thymic epithelial carcinoma is m......
Expression and clinical value of programmed cell death-ligand 1 (PD-L1)in diffuse large B cell lymph
Background: The programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway inhibits the activation of......
Prognostic value of programmed death.1, programmed death-ligand 1, programmed death-ligand 2 express
Background: Anti-programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) immunotherapy has been proved to be effective......
Human tumors tend to activate the immune systemregulatory checkpoints as a means of escaping immunosurveillance.For inst......
目的:通过大鼠淋巴管畸形(lymphatic malformations,LM)动物模型,探讨抗PD-L1(programmed death ligand 1)治疗在淋巴管畸形中的作......
Immune checkpoints release suppressive signals for T cells, which enable the tumors to escape from immune destruction an......
